A federal judge in Illinois allowed a class action against Biogen Inc. to advance over the drugmaker’s alleged collusion with pharmacy benefit managers to favor its multiple sclerosis drug Tecfidera ...

The Gulf Pain Management Drugs Market was valued at $851.08 million in 2019, and is projected to reach $1,047.91 million by 2027, registering a CAGR of 3.2%. Rise in geriatric population is the major ...

Medical marijuana could soon be reclassified into a medical category that includes prescription drugs like Tylenol with codeine, ketamine and anabolic steroids.

Solutions exist to control the rising costs of pharmaceuticals in employee-funded health insurance plans, but long-entrenched ...

Ostarine held the promise of profound medical treatments. Something unexpected happened on the way to F.D.A. approval.

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

The "Molecular Switch Targeting Therapies Market Landscape, Innovation Pipeline and Commercial Impact 2026" report has been added to ResearchAndMarkets.com's offering. The report is designed to give ...

In the U.S., there are four anthelmintic drug classes: avermectins (macrocyclic lactones), benzimidazoles, imidazothiazoles ...